13F HOLDINGS REPORT
TAKEDA PHARMACEUTICAL CO LTD
Quarter ended Q4 2024 · Filed February 13, 2025 · Accession 0001395064-25-000026
Total Value
$289.0M
Positions
17
Other Managers
1
Confidential Omitted
No
Holdings (17)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HilleVax, Inc. | 43157M102 | 6,724,000 | $111.8M | 38.69% |
| 2 | Denali Therapeutics Inc. | DNLI | 4,214,559 | $86.5M | 29.92% |
| 3 | Phathom Pharmaceuticals, Inc. | PHAT | 3,153,217 | $33.5M | 11.59% |
| 4 | Ovid Therapeutics Inc. | OVID | 5,750,000 | $17.5M | 6.07% |
| 5 | Shattuck Labs, Inc. | STTK | 1,501,061 | $13.4M | 4.64% |
| 6 | Wave Life Sciences Ltd. | WVE | 1,096,892 | $6.8M | 2.34% |
| 7 | Ovid Therapeutics Inc. | OVID | 1,781,996 | $5.4M | 1.88% |
| 8 | Equillium, Inc. | EQ | 1,824,977 | $4.2M | 1.46% |
| 9 | Turnstone Biologics Corp. | 90042W100 | 895,824 | $2.3M | 0.81% |
| 10 | Xilio Therapeutics, Inc. | XLO | 1,475,121 | $1.6M | 0.55% |
| 11 | Wave Life Sciences Ltd. | WVE | 250,000 | $1.5M | 0.53% |
| 12 | Day One Biopharmaceuticals, Inc. | DAWN | 85,840 | $1.4M | 0.49% |
| 13 | American Well Corp | AMWL | 1,554,669 | $1.3M | 0.44% |
| 14 | Rani Therapeutics Holdings, Inc. | RANI | 338,679 | $1.1M | 0.36% |
| 15 | Aerovate Therapeutics, Inc. | 008064107 | 13,580 | $401,561 | 0.14% |
| 16 | Akili, Inc. | 00974B107 | 738,819 | $214,258 | 0.07% |
| 17 | STANDARD BIOTOOLS INC. | LAB | 16,515 | $44,756 | 0.02% |